AstraZeneca's blockbuster breast cancer drug Enhertu will be added to China's state-run health insurance scheme from Jan. 1, ...

Akeso, Inc. (9926. HK) ('Akeso' or the 'Company') is pleased to announce that two of its independently developed, globally ...

China will add 91 drugs to its national medical reimbursement list next year, the National Healthcare Security Administration ...

AstraZeneca's (NASDAQ:AZN) blockbuster cancer medication, Enhertu, developed with Japanese pharma giant Daiichi Sankyo (OTCPK ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

Current list price: GLP-1 medications range from $855 to $1,349.02 per month, depending on the medication, dose, and pharmacy. The out-of-pocket cost can vary depending on what insurance covers.

Recalls were initiated over concerns that ranged from potential contamination to the mislabeling of ingredients.

Innovent Biologics (HK:1801) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...

ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to ...

A new bill has been introduced by lawmakers, including two in Virginia, to address drug shortages in the U.S. The End Drug ...

The three largest pharmacy benefit managers — or PBMs — earlier this month went to court to quash a suit by the Federal Trade ...

And how much does it really cost to bring a drug to market? Increasingly, though, these debates are happening when everyone knows that the list price is not the ‘real’ price to be paid ...